Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: Establishment of KT293, a novel G-CSF-secreting melanoma cell line

Cancer Biology and Therapy

Volumn 4, Issue 1, 2005, Pages 30-34

  Schniewind, Bodo ^a,b   Christgen, Matthias ^a   Hauschild, Axel ^a   Kurdow, Roland ^a   Kalthoff, Holger ^a   Klomp, Hans Jürgen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Clinic of General Surgery and Thoracic Surgery   (Germany)

Author keywords

CD68; G CSF; gp100; Granulocyte infiltration; Melanoma; Paraneoplastic leukemoid reaction; Pseudoleukemia; S100; Splenomegaly; Sulesomab

Indexed keywords

CD68 ANTIGEN; GLYCOPROTEIN GP 100; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; NEUTRALIZING ANTIBODY; PROTEIN S 100;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; INOCULATION; ISOTOPE LABELING; LEUKEMOID REACTION; LEUKOCYTE COUNT; MALE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PARANEOPLASTIC LEUKEMOID REACTION; PARANEOPLASTIC SYNDROME; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SCID MOUSE; SPLENOMEGALY; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; DISEASE COURSE; FEMALE; IMMUNOHISTOCHEMISTRY; LEUKOCYTOSIS; MIDDLE AGED; MOUSE MUTANT; PATHOLOGY; SECRETION; SKIN TUMOR;

ANIMALS; DISEASE PROGRESSION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTOSIS; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, SCID; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PHENOTYPE; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 24644504829     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.1.1447     Document Type: Article

References (30)

1. Ito N, Matsuda T, Kakehi Y, Takeuchi E, Takahashi T, Yoshida O. Bladder cancer producing granulocyte colony-stimulating factor. NEJM 1990; 323:1709-10.
2. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MA. Purification and biochemical characterization of a human pluripotent hematopoetic colony-stimulating factor. PNAS 1985; 82:1520-30.
3. Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocyts labeled with poor prognosis in patients with lung carcinoma. Cancer 2001; 92:2399-405.
4. Katoh Y, Nakamura M, Ohnishi Y, Shimamura K, Ueyama Y, Tamaoki N. Autonomous production of granulocyte-colony stimulating factor in tumor xenografts associated with leucocytosis. Br J Cancer 1993; 68:715-9.
5. Miller JI, Sarver RG, Drach GW. Leukemoid reaction: A rare paraneoplastic syndrome associated with advanced bladder carcinoma. Urology 1994; 44:444-6.
6. Satoh H, Abe Y, Katoh Y, Komine Y, Nakamura M, Tamaoki N. Bladder carcinoma producing granulocyte colony-stimulating factor: A case report. J Urol 1993; 149:843-5.
7. Lilly MB, Devlin PE, Devlin JJ, Rado TA. Production of granulocyte colony-stimulating factor by a human melanoma cell line. Exp Hematol 1987; 15:966-71.
8. de Wolff JF, Planken EV, den Ottolander GJ. Extreme leucocytosis and splenomegaly in metastasised melanoma. Neth J Med 2004; 62:164-7.
9. Jaffee EM, Schutte M, Gossett J, Morsberger LA, Adler AJ, Thomas M, Greten TF, Hruban RH, Yeo CJ, Griffin CA. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J Sci Am 1998; 4:194-203.
10. Kampen WU, Brenner W, Terheyden H, Bohuslavizki KH, Henze E. Decisive diagnosis of infected mandibular osteoradionecrosis with a Tc-99m-labelled anti-granulocyte Fab'-fragment. Nuklearmedizin 1999; 38:309-11.
11. Gerdes J, An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery. Int J Cancer 1985; 35:169-71.
12. Takatani H, Soda H, Fukuda M, Watanabe M, Kinoshita A, Nakamura T, Oka M. Levels of Recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts. Antimicrobial Agents Chemother 1996; 40:988-91.
13. Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y, Ishihara K. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 1982; 50:912-8.
14. Adema GJ, de Boer AJ, Vogel AM, Loenen WAM, Figdor CG. Molecular Characterization of the melanocyte linage-specific antigen gp100. J Biol Chem 1994; 269:20126-33.
15. Adema GJ, Bakker AB, de Boer AJ, Hohenstein P, Figdor CG. pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL. Br J Cancer 1996; 73:1044-8.
16. Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 1994; 179:1005-9.
17. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81:1607-13.
18. Shah IA, Gani OS, Wheler L. Comparative immunoreactivity of CD-68 and HMB45 in malignant melanoma, neural tumors and nevi. Pathol Res Pract 1997; 193:497-502.
19. Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, Nishi T, Amano Y. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 1995; 55:3438-43.
20. Chakraborty A, White SM, Lerner SP. Granulocyte colony-stimulating factor receptor signals for betal-integrin expression and adhesion in bladder cancer. Urology 2004; 63:177-83.
21. Safarians S, Rivera SP, Sternlicht MD, Naeim F, Barsky SH. Ectopic G-CSF expression in human melanoma lines marks a trans-dominant pathway of tumor progression. Am J Pathol 1997; 50:949-62.
22. Bober LA, Grace MJ, Pugliese-Sivo C, Rojas-Triana A, Waters T, Sullivan LM, Narula SK. The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology 1995; 29:111-9.
23. Pekarek LA, Starr BA, Toledano AY, Schreiber H. Inhibition of tumor growth by elimination of granulocytes. J Exp Med 1995; 181:435-40.
24. Tazawa H, Okada F, Kobayashi T, Tada M, Mori Y, Une Y, Sendo F, Kobayashi M, Hosokawa M. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: Implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 2003; 163:2221-32.
25. Matsumoto Y, Saiki I, Murata J, Okuyama H, Tamura M, Azuma I. Recombinant human granulocyte colony-stimulating factor inhibits the metastasis of hematogenous and non-hematogenous tumors in mice. Int J Cancer 1991; 49:444-9.
26. Kawakami Y, Robbins PF, Wang RF, Parkhurst M, Kang X, Rosenberg SA. The use of melanosomal proteins in the immunotherapy of melanoma J Immunother 1998; 21:237-46.
27. Sfondrini L, Morelli D, Bodini A, Colnaghi MI, Menard S, Balsari A. High level antibody response to retrovirus-associated but not to melanocyte lineage-specific antigens in mice protected against B16 melanoma. Int J Cancer 1999; 83:107-12.
28. Hayashi H, Matsubara H, Yokota T, Kuwabara I, Kanno M, Koseki H, Isono K, Asano T, Taniguchi M. Molecular cloning and characterization of the gene encoding mouse melanoma antigen by cDNA library transfection. J Immunol 1992; 149:1223-9.
29. Franzke A, Piao W, Lauber J, Gatzlaff P, Konecke C, Hansen W, Schmitt-Thomsen A, Hertenstein B, Buer J, Ganser A. G-CSF as immune regulator in T cells expressing the G-CSF receptor: Implications for transplantation and autoimmune diseases. Blood 2003; 102:734-9.
30. Weiss L, Or R, Slavin S, Naparstek E, Reich SAbdul-Hai A. Immunotherapy of murine leukaemia following nonmyeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells. Canncer Immunol Immunother 2004; 53:358-62.